One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial.

1992139 citationsJournal Articlebronze Open Access

Authors

David O. Williams · Brown University

Eugene Braunwald · Brown University

Genell L. Knatterud · Brown University

Joseph D. Babb · Brown University

John Bresnahan · Rhode Island Hospital

M A Greenberg · Rhode Island Hospital

Albert E. Raizner ·

Abstract

The INV and CON strategies resulted in similar favorable outcomes at 1 year of follow-up. In particular, the rates of mortality and reinfarction were not different and were impressively low in both groups. One possible advantage of the INV strategy was detected in subgroup analyses. In patients with a history of myocardial infarction, the data are suggestive that 1-year mortality was lower in INV patients (10.3%) than in CON patients (17.0%) (p = 0.03).

Topics & Keywords

Lymphoma Diagnosis and Treatment Acute Myocardial Infarction Research Coronary Interventions and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 85, Issue 2, pp. 533-542

DOI: 10.1161/01.cir.85.2.533

Field-Weighted Citation Impact: 17.83